An Open-Label Study of the Effect of an Ophthalmic Solution on Asteroid Hyalosis

Phase 2

• Conditions: Asteroid Hyalosis
• Interventions: Drug: C-KAD Ophthalmic Solution

• Registration Number: NCT00825942
• Lead Sponsor: Chakshu Research, Inc.

Brief Summary

To determine the safety and initial efficacy of C-KAD ophthalmic solution in patients with asteroid hyalosis

Detailed Description

Not available

Study Timeline

• Study Start: 2008-07
• Study First Submitted: 2009-01-19
• Study First Submitted QC: 2009-01-19
• Study First Posted: 2009-01-21
• Status Verified: 2009-04
• Last Update Submitted: 2009-04-16
• Last Update Posted: 2009-04-17
• Primary Completion: 2009-10
• Study Completion: 2009-11

Recruitment & Eligibility

• Status: UNKNOWN
• Sex: All
• Target Recruitment: 20

Inclusion Criteria

• Presence of asteroid hyalosis

Exclusion Criteria

• Active ocular infection
• Glaucoma
• Ocular hypertension
• Ocular inflammatory disorders

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: SINGLE_GROUP

Arm && Interventions

Group	Intervention	Description
C-KAD Ophthalmic Solution	C-KAD Ophthalmic Solution	-

Primary Outcome Measures

Name	Time	Method
Reduction in the number of asteroid bodies	180

Trial Locations

Locations (1)

Mountain View Optometry and Contact Lens Clinic; 🇺🇸 Mountain View, California, United States